5 things to watch on the ASX 200 on Friday

MotleyFool
07-04

On Thursday, the S&P/ASX 200 Index (ASX: XJO) fought hard but slipped into the red. The benchmark index fell slightly to 8,595.8 points.

Will the market bounce back from this on Friday and end the week on a high? Here are five things to watch:

ASX 200 expected to rise

The Australian share market looks set to rise on Friday following a strong night in the United States. According to the latest SPI futures, the ASX 200 is expected to open 26 points or 0.3% higher this morning. On Wall Street, the Dow Jones was up 0.8%, the S&P 500 rose 0.8%, and the Nasdaq stormed 1% higher.

Oil prices fall

It could be a subdued finish to the week for ASX 200 energy shares Santos Ltd (ASX: STO) and Karoon Energy Ltd (ASX: KAR) after oil prices dropped overnight. According to Bloomberg, the WTI crude oil price is down 0.45% to US$67.15 a barrel and the Brent crude oil price is down 0.35% to US$68.88 a barrel. Oil prices fell on US tariff and OPEC uncertainty.

Sell Lynas shares

Lynas Rare Earths Ltd (ASX: LYC) shares are expensive according to analysts at Bell Potter. This morning, the broker has reaffirmed its sell rating with a reduced price target of $6.05. It said: "We maintain our sell recommendation and reduce our target price to $6.05/sh (previously $6.25/sh). Whilst we like the business, asset, and team, we believe there is significant optimism priced into the stock, with investors using it as a hedge on USChina relations. LYC is well poised, if or when, the tides shift for NdPr, with sufficient installed capacity and leverage."

Gold price falls

ASX 200 gold shares Evolution Mining Ltd (ASX: EVN) and Northern Star Resources Ltd (ASX: NST) could have a poor finish to the week after the gold price fell overnight. According to CNBC, the gold futures price is down 0.7% to US$3,336.4 an ounce. This was driven by the release of strong US economic data which has reduced rate cut hopes.

Pro Medicus shares downgraded

Pro Medicus Ltd (ASX: PME) will be on watch today after analysts at Bell Potter downgraded the high-flying health imaging technology company's shares. The broker has downgraded its shares to a hold rating (from buy) with an improved price target of $320.00 (from $280.00). In response to a new contract win, the broker said: "Revenues are increased by ~3% in FY26. Earnings increases are negligible. PT is increased to $320, recommendation is downgraded to Hold from Buy based on movement in valuation."

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10